I agree that this site is using cookies. You can find further informations here.
X
Melotek, J.M.
~ 0  results:
Search for persons X
?
1

Safety and Efficacy of a Randomized Phase I Trial to Evalua..:

Chmura, S.J. ; Bestvina, C.M. ; Karrison, T.G....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. S72 , 2020
Link: https://doi.org/10.1016/..
 
?
2

OPTIMA: a phase II dose and volume de-escalation trial for ..:

Seiwert, T.Y. ; Foster, C.C. ; Blair, E.A....
Annals of Oncology.  30 (2019)  10 - p. 1673 , 2019
Link: https://doi.org/10.1093/..
 
?
3

Dose and Volume De-Escalation for HPV-Positive Oropharyngea..:

Foster, C.C. ; Seiwert, T.Y. ; MacCracken, E....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. E419 , 2019
Link: https://doi.org/10.1016/..
 
?
4

OPTIMA—A Phase 2 Trial of Induction Chemotherapy Response-S..:

Seiwert, T. ; Melotek, J.M. ; Foster, C.C....
International Journal of Radiation Oncology*Biology*Physics.  100 (2018)  5 - p. 1309 , 2018
Link: https://doi.org/10.1016/..
 
?
5

Interfraction Variability in the Position of Soft-Tissue St..:

Tatebe, K. ; Malin, M. ; Melotek, J.M..
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e487 , 2018
Link: https://doi.org/10.1016/..
 
?
6

A Phase 2 Dose and Volume De-escalation Trial for High- and..:

Melotek, J.M. ; Seiwert, T.Y. ; Blair, E.A....
International Journal of Radiation Oncology*Biology*Physics.  99 (2017)  2 - p. S135 , 2017
Link: https://doi.org/10.1016/..
 
?
7

The ADscopal Effect? Control of Partially Irradiated Versus..:

Lemons, J.M. ; Luke, J.J. ; Janisch, L....
International Journal of Radiation Oncology*Biology*Physics.  99 (2017)  2 - p. S87 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Definitive Chemoradiation Therapy for Advanced Oral Cavity ..:

Melotek, J.M. ; Brisson, R.J. ; Villaflor, V.M....
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  2 - p. S84 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Final Results of a Randomized Phase 2 Trial Investigating t..:

Melotek, J.M. ; Haraf, D.J. ; Blair, E.A....
International Journal of Radiation Oncology*Biology*Physics.  94 (2016)  4 - p. 867 , 2016
Link: https://doi.org/10.1016/..
 
?
10

Response-Adapted Volume De-escalation (RAVD) in Locally Adv..:

Melotek, J.M. ; Villaflor, V.M. ; Karrison, T.G....
International Journal of Radiation Oncology*Biology*Physics.  94 (2016)  4 - p. 865 , 2016
Link: https://doi.org/10.1016/..
 
?
11

Weekly Versus Every-3-Weeks Platinum-Based Chemoradiation R..:

Melotek, J.M. ; Cooper, B.T. ; Koshy, M...
International Journal of Radiation Oncology*Biology*Physics.  94 (2016)  4 - p. 879 , 2016
Link: https://doi.org/10.1016/..
 
?
12

Response-Adapted Volume De-escalation (RAVD) in Locally Adv..:

Melotek, J.M. ; Villaflor, V.M. ; Karrison, T.G....
International Journal of Radiation Oncology*Biology*Physics.  94 (2016)  4 - p. 877-878 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Pooled Analysis of Late Toxicity From 2 Randomized Phase 2 ..:

Melotek, J.M. ; Villaflor, V.M. ; Seiwert, T.Y....
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  2 - p. E351-E352 , 2016
Link: https://doi.org/10.1016/..
 
?
14

E2F1 Mediates Human Papillomavirus (HPV) Oncogene Toxicity ..:

Spiotto, M.T. ; Zhong, R. ; Melotek, J.M..
International Journal of Radiation Oncology*Biology*Physics.  94 (2016)  4 - p. 936-937 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Omission of the Pathologic Node-Negative Neck from Postoper..:

Melotek, J.M. ; Brisson, R.J. ; Haraf, D.J.
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  2 - p. E360 , 2016
Link: https://doi.org/10.1016/..
 
1-15